Is This Volume Any Indicator Of A New Trend?MRKR has been a sleeper all year. No major high-volume days and nothing really to write home about. But it managed to pull off a bigger move earlier on. Now that the gap has filled from the drop a few weeks ago & they secured funds, what will this mean for the company's next steps?
"An onslaught of Form 4s showed hand fulls of investors and insiders participating in the recent offering. The company raised the money to fund its Phase 2 trial of MT-401 in acute myeloid leukemia. Marker also plans to develop MultiTAA therapies into clinical trials in other indications and conduct manufacturing activities, among other things.
In addition to this, analysts have also weighed in recently. Cantor Fitzgerald initiated coverage on Marker this month. The firm started MRKR at Overweight and gave a price target of $6."
Quote Source: Best Penny Stocks On Robinhood To Watch This Week If You Like Biotech
Pennystocks
SELB Back In High TrafficSELB is back in the upper area of its high-traffic support/resistance from several times prior. Most recently, it saw this act as support in February. But it wasn't able to sustain the level. Anyway, it's back at this but in this case, the level has acted as a potential resistance (for now). It's gonna be interesting to see what happens next.
Selecta seems to have benefited from a bullish outlook discussed by the company in its last corporate update.
“We are very pleased by the continued progress of our gene therapy program. In collaboration with AskBio, our lead program in methylmalonic acidemia, is on track to enter the clinic in the second quarter of this year, and we expect initial data by the end of the year,” said Carsten Brunn, Ph.D., president, and chief executive officer of Selecta.
“A key objective of 2021 will be to generate human data in our gene therapy programs and to continue to build our extensive pipeline in gene therapies, enzyme therapies–with an expected IND filing by the end of the year in IgA nephropathy–and autoimmune diseases, as we work to deliver on our mission to leverage our pioneering ImmTOR platform to improve the lives of patients and their families.”
Quote Source: Best Penny Stocks On Robinhood To Watch This Week If You Like Biotech
MBOT Stock Breakout!Hi, this is my first time here I'm just a beginner in day trading on stocks and I want to share my ideas about the simple resistance/support levels strategy. Although I see a flag pattern and a nearly breakout coming specially if it won't break the 3 support levels. on the other hand if it did a touch on the down trendline with a pullback it will be a very bullish sign.
Again I'm just a beginner who wants to apply what he learns, I will be appreciated if someone discussed this technical analysis with me!
Thanks.
First Penny Stock Added to the Trade Watchlist? KIQKIQ following trend pretty well. Adding this one to watchlist.
Many of these are in pivot points of uptrends.
Included
TAP
GRPN
GDDY
ON
GLW
DHR
NET
PFPT
CLDR
Breakout, followed by retest of fib lineGreat continuation of uptrend, slow stochastic yesterday signaled a needed reset. Retested new fib line support with a strong bounce, need to retest next fib line resistance to continue uptrend.
Earnings coming out this month, partnership announced today, looks to be a strategic partnership to capitalize on each company's competitive advantages in the space. Surna in joining forces with a competitor rather than fighting for market share.
NOKIA ($NOK) gearing up for big move? 📈🚀 Penny stock breakout?$NOK is forming a rounding accumulation pattern with a bullish MACD crossover and an upward-trending RSI. The OBV (on balance volume) is also looking to break out with the same rounding accumulation pattern.
From a fundamental standpoint, $NOK has actually been fairly active on the contractual front. It recently picked up a few 5G contracts from large operators like Telenet in Belgium, A1 in Austria, and Orange. It has also signed a partnership with Microsoft ($MSFT) to develop private wireless products specifically designed for enterprises.
$NOK could fairly easily break to the $4.75 - $5 range fairly soon, barring an overall market retracement.
APMP long off todays closeToday's close above $1.11 should send it up to test the red line ($1.30ish) on the chart. Above that, we head North quickly.
Klondike Silver - Ready for the Next Move UpWe are getting a double retest of December's breakout point. Assuming OTC:KLSVF does not lose support, we are expecting much HIGHER prices in the weeks ahead.
The featured content is intended to be used for informational purposes only. Everything shared here is my own opinion. It is very important to do your own analysis before making any investment based on your own personal circumstances. Please subscribe to our channel if you like what you are seeing!
$EXPR can rise in the next daysContextual immersion trading strategy idea.
Express, Inc. operates as an apparel and accessories retailer.
The demand for shares of the company looks higher than the supply.
This and other conditions can cause a rise in the share price in the next days.
So I opened a long position from $4,25;
stop-loss — $3,41.
Information about take-profits will be later.
Do not view this idea as a recommendation for trading or investing. It is published only to introduce my own vision.
Always do your own analysis before making deals. When you use any materials, do not rely on blind trust.
You should remember that isolated deals do not give systematic profit, so trade/invest using a developed strategy.
If you like my content, you can subscribe to the news and receive my fresh ideas.
Thanks for being with me!
$AMPG can rise in the next daysContextual immersion trading strategy idea.
AmpliTech Group, Inc. designs, engineers, and assembles micro-wave component based amplifiers.
The demand for shares of the company looks higher than the supply.
This and other conditions can cause a rise in the share price in the next days.
So I opened a long position from $11,03;
stop-loss — $9,51.
Information about take-profits will be later.
Do not view this idea as a recommendation for trading or investing. It is published only to introduce my own vision.
Always do your own analysis before making deals. When you use any materials, do not rely on blind trust.
You should remember that isolated deals do not give systematic profit, so trade/invest using a developed strategy.
If you like my content, you can subscribe to the news and receive my fresh ideas.
Thanks for being with me!
$OGI can rise in the next daysContextual immersion trading strategy idea.
Organigram Holdings Inc., through its subsidiaries, produces and sells cannabis and cannabis-derived products in Canada.
The demand for shares of the company looks higher than the supply.
This and other conditions can cause a rise in the share price in the next days.
So I opened a long position from $4,44;
stop-loss — $3,71.
Information about take-profits will be later.
Do not view this idea as a recommendation for trading or investing. It is published only to introduce my own vision.
Always do your own analysis before making deals. When you use any materials, do not rely on blind trust.
You should remember that isolated deals do not give systematic profit, so trade/invest using a developed strategy.
If you like my content, you can subscribe to the news and receive my fresh ideas.
Thanks for being with me!
Back At Historical S/R Level On ISRISR has been something of a sight in this market. Now, after pulling in and settling down a bit, it's back at the historic support/resistance level. With momentum acting as a tailwind in biotech stocks, overall, I'll be interested to see if it can get back above this level in more of a "calm fashion" haha.
While fewer surgeries occurred last year due to covid, IsoRay has managed to work around this, building its brachytherapy use cases along the way. CEO Lori Woods stated that “we are very pleased that we have been able to continue to make progress this quarter despite the ongoing challenges that the Covid-19 pandemic has presented. Amongst the highlights has been our continued success in expanding adoption of Celsium-131 in our core prostate market.”
Quote Source: 5 Biotech Penny Stocks On Robinhood To Watch In March 2021
Breakout on volumeBroke several resistance levels today, need a close above the fib line, will get us back in the uptrend (purple line).
Approaching a High Traffic Area on The ChartThe CHS stock chart is at a level where we saw some high traffic a while back. This has previously been a level of support, now apparent resistance. But can the reopening momentum act as an afterburner for the penny stock?
Chico’s FAS is another apparel retailer owning popular niche brands like Chico’s, White House Black Market, and Soma Intimates. It, too, has taken up a larger focus on digital sales. In its latest quarterly filing, Soma, for instance, saw its highest sales in the history of the brand. Comparable sales were also up over 15%, and it was driven by an uptick (over 68%) in digital sales. What’s more, total company Q4 and year-to-date digital sales increased almost 20%, according to Chico’s.
Quote Source: 5 Penny Stocks For Your March 2021 Reopening Watch List
Will Reopening Trigger a final Break for AHT?I know the reopening trade idea is in play right now but how strong is the sentiment? We still need stimulus to come out, more vaccines, more everything. So where does AHT go from here? Fibs look interesting too. NYSE:AHT
Aside from the industry sentiment, Ashford has been fundamentally making strides in preparation for a hopefully bullish return to the market. This included exchanging some of its preferred shares for common stock. We’ve also seen analysts take a more bullish stance on AHT. Most recently, B. Riley adjusted its price target on the penny stock. In this case it bumped the previous $2.50 target to $3 and currently maintains a Neutral rating on the company.
Let's see if travel picks up this year. If that happens, I can't think hotel operators will stay suppressed.
Quote Source: 5 Penny Stocks For Your March 2021 Reopening Watch List
LKCO At Key LevelI know we saw a strong day today but here it is at a frequent technical level it has had a hard time breaking above before. Can it do it again?
This is where we’ve seen stocks like LKCO NASDAQ:LKCO surge this year. If you look back at the start of 2021, the penny stock was trading around $0.70 and ended up rallying as high as $3.86 last month. Similar to many stocks, Luokung shares slid during the second half of February. This was mainly in response to a $100 million financing round the company formally closed on February 22nd.
Luokong is a big data processing company designing location-based services for customers in China. Its Luokuang and Superengine brands provide spatial-temporal big data via PaaS, SaaS, and DaaS services. While things like the “Internet Of Things” has captivated tech traders, there’s something else going on with LKCO that has traders’ attention right now.
Quote Source: 5 Hot Penny Stocks To Buy Under $1 In March 2021
Trade alert: OPGNPoints of interest on chart.
We might have another day or two of movement upwards.
This can go either way (predicted green and red zone in chart) Be careful!
*Please leave a like if you find this useful, thanks*
$MICT can rise in the next daysContextual immersion trading strategy idea.
MICT, Inc., operating through its subsidiaries GFH Intermediate Holdings Ltd. and Micronet Ltd, provides mobile computing solutions; as well as a proprietary trading technology platform for high growth sectors in global fintech space.
The demand for shares of the company looks higher than the supply.
This and other conditions can cause a rise in the share price in the next days.
So I opened a long position from $2,96;
stop-loss — $2,61.
Information about take-profits will be later.
Do not view this idea as a recommendation for trading or investing. It is published only to introduce my own vision.
Always do your own analysis before making deals. When you use any materials, do not rely on blind trust.
You should remember that isolated deals do not give systematic profit, so trade/invest using a developed strategy.
If you like my content, you can subscribe to the news and receive my fresh ideas.
Thanks for being with me!
$STXS can rise in the next daysContextual immersion trading strategy idea.
Stereotaxis, Inc. designs, manufactures, and markets robotic magnetic navigation (RMN) systems for use in hospital's interventional surgical suite to enhance the treatment of arrhythmias and coronary artery disease in the United States and internationally.
The demand for shares of the company looks higher than the supply.
This and other conditions can cause a rise in the share price in the next days.
So I opened a long position from $7,95;
stop-loss — $6,89.
Information about take-profits will be later.
Do not view this idea as a recommendation for trading or investing. It is published only to introduce my own vision.
Always do your own analysis before making deals. When you use any materials, do not rely on blind trust.
You should remember that isolated deals do not give systematic profit, so trade/invest using a developed strategy.
If you like my content, you can subscribe to the news and receive my fresh ideas.
Thanks for being with me!
$APEN can rise in the next daysContextual immersion trading strategy idea.
Apollo Endosurgery, Inc., a medical technology company, focuses on the design, development, and commercialization of medical devices.
The demand for shares of the company looks higher than the supply.
This and other conditions can cause a rise in the share price in the next days.
So I opened a long position from $6,10;
stop-loss — $5,00.
Information about take-profits will be later.
Do not view this idea as a recommendation for trading or investing. It is published only to introduce my own vision.
Always do your own analysis before making deals. When you use any materials, do not rely on blind trust.
You should remember that isolated deals do not give systematic profit, so trade/invest using a developed strategy.
If you like my content, you can subscribe to the news and receive my fresh ideas.
Thanks for being with me!